-year performance which has already factored into the Company’s annual growth forecast. Meanwhile, we already have seen signs of improvement in overall advertising sentiment in upcoming November and

/2017 (for the equity holders of the Company) was THB 36.65 million, an increase of THB 8.85 million or of 31.83% from the same period last year (Q3/2017 : THB 27.80 million). The Growth in revenues and

-47.86 million, Baht - 50.16 million and Baht -29.12 million in Q1, Q2 and Q3 2017 respectively. Considering the sustainable growth, the company is in the process of launching the new business concept with

the main trading currency of the company), resulting in the company recognized revenue from sales of foreign currency decreased For domestic market, revenue from sales increase lightly due to growth of

, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the

will meet the demand of the customers, which will increase Company’s competitiveness and continuously maintain growth rate of the Company. (9) Source of Funds : The Subsidiary will use its term loans and

expenses in proportional to sale decreased from sales growth. Please be informed accordingly Sincerely yours Panjawattana Plastic PCL. 28 Moo 2, Tumbol Chaimongkol, Amphur Muang, Samutsakhon 74000

period of last year by Baht 44.2 million or 12.9%. The major reason for the incremental is from same store sale growth at 10.5% and new branches opened during the year 2018 at 6.8%. Which during the period

result of new branch opening at The Mall Bangkapi in October 2018, resulting in the growth in this quarter revenue recognition compared to last year. Moreover, the group has opened a new branch at Central

. Total revenue from sale of goods in the number of 10,579.2 million Baht was increased by 972.1 million Baht or 10.1% from the previous fiscal year. The sale growth rates compared to the previous fiscal